The split that the company needs to happen is coming soon, I see the $.90 cent to $1.00 rang a good idea to drop around there. The company has a lot of very interesting eye relief coming as well as far new genetic eye improvement implementations coming in 2021. Not to mention one of the key players is associated with the FDA. Even if you were to buy now I don't...
